Divi's Laboratories Osake

Divi's Laboratories EV/FCF

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Divi's Laboratories (DIVISLAB.NS) 6.8.2026 päivämäärällä on 756,81. Edellisenä vuonna EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) oli 630,87 — muutos 19,96 % (korkeampi).

EV/FCF

756,81

YoY

19,96%

Viimeksi päivitetty:

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Divi's Laboratories on 2026 756,81 . EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Divi's Laboratories oli 2025 630,87 . Se laskee 19,96% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Divi's Laboratories Osakeanalyysi

Mitä Divi's Laboratories tekee? Divi's Laboratories Ltd. is a pharmaceutical company based in Hyderabad, India. It was founded in 1990 and has become one of the leading manufacturers of active ingredients and formulations for the pharmaceutical industry in recent years. The company was founded by Dr. Murali Divi, who built the company on principles of quality, technology, and innovation. Divi's Laboratories now employs approximately 13,000 employees and operates production facilities in India and the USA. The company operates in various sectors, including generics, custom synthesis, research and development, and nutraceuticals. Its products are used worldwide and are approved in over 95 countries. Divi's Laboratories follows a vertically integrated supply chain model, producing high-quality active ingredients and developing its own formulations for the pharmaceutical industry. The company always relies on innovative technologies and continuous improvement of product quality. Its product range includes a wide range of active ingredients for various therapeutic areas, such as antibiotics, antidepressants, antihypertensives, antidiabetics, static lipid-lowering agents, and antipsychotics. Divi's Laboratories has state-of-the-art production facilities, strict quality controls, and advanced analytical facilities for all pharmaceutical ingredients. In addition to its active ingredients, the company is also known for its custom synthesis services, which involve the production of customer-specific active ingredients for the pharmaceutical industry. Divi's Laboratories offers a tailored service that meets the specific requirements of customers, ranging from the development of new active ingredients and formulations to the production of small or medium quantities of active ingredients. In the area of research and development, Divi's Laboratories works closely with academic institutions and other pharmaceutical companies to leverage the latest scientific knowledge and develop innovative products. The company invests a significant sum in research and development annually. In addition to active ingredients and custom synthesis services, Divi's Laboratories also offers a range of nutraceuticals. These products, such as vitamins, minerals, and other dietary supplements, are used to support a healthy lifestyle. In summary, Divi's Laboratories is an India-based pharmaceutical company specializing in the manufacture of active ingredients and formulations for the pharmaceutical industry. The company operates to the highest quality standards and relies on innovative technologies and sustainable product development. The wide product range and custom synthesis services offer customers a tailored solution for their needs. Divi's Laboratories is a leading provider of active ingredients and has made a name for itself in the pharmaceutical and nutraceutical industry due to its high quality and productivity. Divi's Laboratories on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Divi's Laboratories osakkeesta

Yhtiön Divi's Laboratories EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) on 756,81 vuonna 2026.

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Divi's Laboratories muuttui arvosta 630,87 arvoon 756,81, mikä edustaa 19,96 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) Divi's Laboratories:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EV/FCF-suhde mittaa yrityksen arvoa suhteessa vapaaseen kassavirtaan. Se heijastaa yrityksen todellista kassantuottokykyä.

Arvioidakseen EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):n Divi's Laboratories alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Divi's Laboratories

Kaikki tunnusluvut — Divi's Laboratories